Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics and head of the Aran Lab at Keck Graduate Institute (KGI) and Chief Scientific Officer of Cardea Bio, was recently selected for a significant grant from the National Institutes of Health (NIH). This grant helps develop CRISPR Quality Control standards for therapeutics applications in this groundbreaking area of science, starting with a focus on Sickle Cell Disease. The award covers 1.63 million dollars in funding over four years.
